The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC).
 
Julie E. Bauman
Consulting or Advisory Role - AstraZeneca/MedImmune; CUE Biopharma; Merck Serono
Research Funding - AstraZeneca (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); CUE Biopharma (Inst); Lilly (Inst); Moderna Therapeutics (Inst); Novartis (Inst)
 
Nabil F. Saba
Honoraria - BioNTech; CUE Biopharma; Merck
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Blueprint Medicines; GlaxoSmithKline; Merck; Pfizer
 
Denise Roe
No Relationships to Disclose
 
Jessica R. Bauman
Consulting or Advisory Role - AstraZeneca; Kura Oncology; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Trident Pharmaceuticals
 
John M. Kaczmar
Consulting or Advisory Role - Bicara Therapeutics; Rakuten Medical; Regeneron
 
Aarti K. Bhatia
Honoraria - Clinical Care Options
Consulting or Advisory Role - Merck; Sanofi/Regeneron
Research Funding - Boehringer Ingelheim
 
Jameel Muzaffar
No Relationships to Disclose
 
Ricklie Ann Julian
No Relationships to Disclose
 
Steven Wang
No Relationships to Disclose
 
Shethal Bearelly
No Relationships to Disclose
 
Audrey Baker
No Relationships to Disclose
 
Conor Ernst Steuer
Honoraria - Merck
Consulting or Advisory Role - Abbvie; ARMO BioSciences; BerGenBio; Lilly
Research Funding - Daiichi Sankyo; Infinity Pharmaceuticals; Seagen; Vaccinex
 
Anshu Giri
No Relationships to Disclose
 
Barbara Burtness
Consulting or Advisory Role - Aduro Biotech; ALX Oncology; Celgene; CUE Biopharma; Debiopharm Group; IO Biotech; Ipsen; Macrogenics; Maverick Therapeutics; Merck; Nanobiotix; Oncolys BioPharma; Rakuten Medical
Research Funding - Aduro Biotech (Inst); Bristol Myers (Inst); CUE Biopharma (Inst); Exelixis (Inst); Formation Biologics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Debiopharm Group; Merck
 
Sara Centuori
No Relationships to Disclose
 
Carlos Caulin
No Relationships to Disclose
 
Kathylynn Saboda
No Relationships to Disclose
 
Stefanie Obara
No Relationships to Disclose
 
Christine H. Chung
Consulting or Advisory Role - Bristol-Myers Squibb; CUE Biopharma; Mirati Therapeutics; Sanofi/Regeneron
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Ignyta (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Mirati Therapeutics